In a Type I insulin-dependent diabetes mellitus patient, if fructosamine indicates improving metabolic control, what state is the patient in?

In a Type I insulin-dependent diabetes mellitus patient, if fructosamine indicates improving metabolic control, what state is the patient in?

• A. 'steady state' of metabolic control
• B. state of flux progressively worsening metabolic control
• C. improving state of metabolic control as indicated by fructosamine
• D. state of flux indicted by the fasting glucose level

Answer: (C)

Fructosamine reflects short-term glycemic control because it measures the glycation of circulating proteins and changes more quickly than HbA1c, capturing roughly the past 1–3 weeks. If fructosamine indicates improving metabolic control, that means the patient’s average blood glucose has been decreasing over that recent period. In a Type I diabetic, this points to an improving state of metabolic control as indicated by fructosamine. This is different from a steady state, where there’s no recent change in control, or a state of flux that’s worsening, which would show increasing fructosamine. The cost or direction of change is tied specifically to what fructosamine is signaling about short-term average glucose, not just fasting glucose alone.

Fructosamine reflects short-term glycemic control because it measures the glycation of circulating proteins and changes more quickly than HbA1c, capturing roughly the past 1–3 weeks. If fructosamine indicates improving metabolic control, that means the patient’s average blood glucose has been decreasing over that recent period. In a Type I diabetic, this points to an improving state of metabolic control as indicated by fructosamine.

This is different from a steady state, where there’s no recent change in control, or a state of flux that’s worsening, which would show increasing fructosamine. The cost or direction of change is tied specifically to what fructosamine is signaling about short-term average glucose, not just fasting glucose alone.